Groin monitoring versus groin surgery for vulvar cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares two ways to check for cancer spread in the groin: a less invasive ultrasound scan versus surgery to remove lymph nodes. The goal is to see if the scan is just as safe and can help avoid extra surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with squamous cell carcinoma or adenocarcinoma of the vulva.
- Your cancer is at an early stage (stage 1b or 2) and has not spread to lymph nodes or other organs.
- You are willing and able to have a sentinel lymph node biopsy or inguinal femoral lymphadenectomy as part of your care.
- You are willing to follow the study schedule and requirements.
- If you are premenopausal or less than 2 years past menopause, you must have a negative pregnancy test within 30 days of surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using ultrasound of the groin can help find cancer spread in the lymph nodes of women with early-stage vulvar cancer. The goal is to see if ultrasound can replace or reduce the need for more invasive surgery.
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
This trial compares two ways of removing lymph nodes in the groin for vulvar cancer: the standard open surgery and a newer robotic-assisted method using a single small hole. The goal is to see if the robotic approach is as effective with fewer side effects.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
This study tests whether a special dye injection can reliably find the first lymph node that might contain cancer in women whose vulvar cancer has come back for the first time. It aims to help doctors know if the cancer has spread without removing many lymph nodes.
Hear when a new Lymph Node Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.